molecular detection of tuberculosis and rifampin resistance.
-
Upload
khaled-alkhodari -
Category
Documents
-
view
42 -
download
0
Transcript of molecular detection of tuberculosis and rifampin resistance.
Rapid Molecular Detection of
Tuberculosis and Rifampin
Resistance.
Presented By : Khaled Alkhodari
Supervised By :Dr. saeb aliwaini
Due to : 26/11/2014
Outline
I. Introduction.
II. Methods.
III. Results.
IV. Conclusion.
2
Introduction
Tuberculosis (TB): is a bacterial infection that can spread through the lymph
nodes and bloodstream to any organ in the body. It is most often found in the
lungs.
Rifampin : is a drug used to treat TB
inhibits bacterial RNA polymerase.
Bacterial resistance to it is caused by mutations in rpoB gene leading to a change
in the structure of the β subunit of RNA polymerase.
3
Methods
Xpert MTB/RIF : an automated molecular test for Mycobacterium
tuberculosis(MTB) and resistance to rifampin (RIF).
Three sputum specimens:
Two specimens were processed with:
N-acetyl-l-cysteine ( NALC ) and sodium hydroxide (NaOH ) before microscopy, solid and
liquid culture.
The MTB/RIF test.
One specimen was used for direct testing with microscopy and the MTB/RIF test.
4
Xpert MTB/RIF Test
5
an automated molecular test for
Mycobacterium tuberculosis(MTB) and
resistance to rifampin (RIF),
polymerasechain-reaction (PCR) assay to
amplify an MTB specific sequence of the
rpoB gene , gene encodes the β subunit of
bacterial RNA-polymerase.
6
(Fig. 1)
7
Results
(Fig. 1 Cont’d)
8
9
10
Conclusion
The MTB/RIF test provided sensitive detection of tuberculosis and rifampin
resistance directly from untreated sputum in less than 2 hours with minimal
hands-on time.
11
12
The authors
Catharina C. Boehme, M.D., Pamela Nabeta, M.D., Doris Hillemann, Ph.D.,
Mark P. Nicol, Ph.D.,
Shubhada Shenai, Ph.D., Fiorella Krapp, M.D., Jenny Allen, B.Tech., Rasim
Tahirli, M.D., Robert Blakemore, B.S.,
Roxana Rustomjee, M.D., Ph.D., Ana Milovic, M.S., Martin Jones, Ph.D., Sean
M. O’Brien, Ph.D.,
David H. Persing, M.D., Ph.D., Sabine Ruesch-Gerdes, M.D., Eduardo Gotuzzo,
M.D., Camilla Rodrigues, M.D.,
David Alland, M.D., and Mark D. Perkins, M.D.
13